Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
6
NCT03436420
Gemcabene for the Treatment of Pediatric NAFLD
Phase: Phase 2
Role: Collaborator
Start: Mar 29, 2018
Completion: Aug 27, 2019